DUBLIN – Crowdfunding and drug repurposing are two current buzz topics in biotech, and it is not difficult to see how the former could be harnessed in support of the latter. Spanish firm Som Biotech SL, however, is discovering that logic alone is not sufficient to guarantee a successful campaign.